Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma

A. M. Pinto, C. Califano, F. Di Gennaro, A. De Renzo, L. Catalano, L. Pace

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Technetium-99m-Sestamibi (99mTc-sestamibi) scintigraphy has been shown to be capable of differentiating patients with multiple myeloma (MM) in remission from those with active disease. We studied 5 patients with MM (2 females and 3 males, age 53±17 years) before and after treatment. 99mTc-sestamibi scintigraphic results were concordant with clinical status.

Original languageEnglish
Pages (from-to)1000-1001
Number of pages2
JournalHaematologica
Volume85
Issue number9
Publication statusPublished - 2000

Fingerprint

Technetium Tc 99m Sestamibi
Physiologic Monitoring
Multiple Myeloma
Radionuclide Imaging
Therapeutics

Keywords

  • 99m Tc-sestamibi
  • Multiple myeloma

ASJC Scopus subject areas

  • Hematology

Cite this

Pinto, A. M., Califano, C., Di Gennaro, F., De Renzo, A., Catalano, L., & Pace, L. (2000). Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma. Haematologica, 85(9), 1000-1001.

Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma. / Pinto, A. M.; Califano, C.; Di Gennaro, F.; De Renzo, A.; Catalano, L.; Pace, L.

In: Haematologica, Vol. 85, No. 9, 2000, p. 1000-1001.

Research output: Contribution to journalArticle

Pinto, AM, Califano, C, Di Gennaro, F, De Renzo, A, Catalano, L & Pace, L 2000, 'Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma', Haematologica, vol. 85, no. 9, pp. 1000-1001.
Pinto AM, Califano C, Di Gennaro F, De Renzo A, Catalano L, Pace L. Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma. Haematologica. 2000;85(9):1000-1001.
Pinto, A. M. ; Califano, C. ; Di Gennaro, F. ; De Renzo, A. ; Catalano, L. ; Pace, L. / Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma. In: Haematologica. 2000 ; Vol. 85, No. 9. pp. 1000-1001.
@article{2ff8f9905beb4862a1e9080bd0e5515b,
title = "Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma",
abstract = "Technetium-99m-Sestamibi (99mTc-sestamibi) scintigraphy has been shown to be capable of differentiating patients with multiple myeloma (MM) in remission from those with active disease. We studied 5 patients with MM (2 females and 3 males, age 53±17 years) before and after treatment. 99mTc-sestamibi scintigraphic results were concordant with clinical status.",
keywords = "99m Tc-sestamibi, Multiple myeloma",
author = "Pinto, {A. M.} and C. Califano and {Di Gennaro}, F. and {De Renzo}, A. and L. Catalano and L. Pace",
year = "2000",
language = "English",
volume = "85",
pages = "1000--1001",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "9",

}

TY - JOUR

T1 - Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma

AU - Pinto, A. M.

AU - Califano, C.

AU - Di Gennaro, F.

AU - De Renzo, A.

AU - Catalano, L.

AU - Pace, L.

PY - 2000

Y1 - 2000

N2 - Technetium-99m-Sestamibi (99mTc-sestamibi) scintigraphy has been shown to be capable of differentiating patients with multiple myeloma (MM) in remission from those with active disease. We studied 5 patients with MM (2 females and 3 males, age 53±17 years) before and after treatment. 99mTc-sestamibi scintigraphic results were concordant with clinical status.

AB - Technetium-99m-Sestamibi (99mTc-sestamibi) scintigraphy has been shown to be capable of differentiating patients with multiple myeloma (MM) in remission from those with active disease. We studied 5 patients with MM (2 females and 3 males, age 53±17 years) before and after treatment. 99mTc-sestamibi scintigraphic results were concordant with clinical status.

KW - 99m Tc-sestamibi

KW - Multiple myeloma

UR - http://www.scopus.com/inward/record.url?scp=0033791154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033791154&partnerID=8YFLogxK

M3 - Article

C2 - 10980649

AN - SCOPUS:0033791154

VL - 85

SP - 1000

EP - 1001

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 9

ER -